Emergence of polymyxin resistance in Gram-negative bacteria

International Journal of Antimicrobial Agents

Volumn 48, Issue 6, 2016, Pages 581-582

  Olaitan, Abiola Olumuyiwa ^a   Li, Jian ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIMETHATE; COLISTIN; POLYMYXIN B; ANTIINFECTIVE AGENT; POLYMYXIN;

ACINETOBACTER BAUMANNII; AGRICULTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DRUG CLASSIFICATION; DRUG RESEARCH; EDITORIAL; ENTEROPATHOGENIC ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; MCR GENE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA; DRUG EFFECTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; POLYMYXINS;

EID: 85000936687     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.11.003     Document Type: Editorial

References (13)

1. [1] US Centers for Disease Control and Prevention, Antibiotic resistance threats in the United States, 2013. 2013, CDC, Atlanta (GA) Available from: http://www.cdc.gov/drugresistance/threat-report-2013/ [Accessed 14 November 2016].
2. [2] Kaye, K.S., Pogue, J.M., Tran, T.B., Nation, R.L., Li, J., Agents of last resort: polymyxin resistance. Infect Dis Clin North Am 30 (2016), 391–414.
3. [3] Li, J., Nation, R.L., Milne, R.W., Turnidge, J.D., Coulthard, K., Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 25 (2005), 11–25.
4. [4] Kempf, I., Fleury, M.A., Drider, D., Bruneau, M., Sanders, P., Chauvin, C., et al. What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe?. Int J Antimicrob Agents 42 (2013), 379–383.
5. [5] Liu, Y.-Y., Wang, Y., Walsh, T.R., Yi, L.-X., Zhang, R., Spencer, J., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16 (2016), 161–168.
6. [6] Kempf I., Jouy E., Chauvin C. Colistin use and colistin resistance in bacteria from animals, 598.
7. [7] Baron S., Hadjadj L., Rolain J.-M., Olaitan A.O. Molecular mechanisms of polymyxin resistance: knowns and unknowns, 583.
8. [8] Giamarellou H. Epidemiology of infections caused by polymyxin-resistant pathogens, 614.
9. [9] Oikonomou, O., Sarrou, S., Papagiannitsis, C.C., Georgiadou, S., Mantzarlis, K., Zakynthinos, E., et al. Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data. BMC Infect Dis, 15, 2015, 559.
10. [10] Capone, A., Giannella, M., Fortini, D., Giordano, A., Meledandri, M., Ballardini, M., et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 19 (2013), E23–30.
11. [11] Tran T.B., Velkov T., Nation R.L., Forrest A., Tsuji B.T., Bergen P.J., et al. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? 592.
12. [12] Pogue J.M., Ortwine J.K., Kaye K.S. Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins? 622.
13. [13] Lenhard J.R., Nation R.L., Tsuji B.T. Synergistic combinations of polymyxins, 607.